Home > Insider Trading > Lifecore Biomedical Inc

Lifecore Biomedical Inc (LFCR)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 20
Next >>

Here's Why Cove Street Capital Reduced its Position in Lifecore Biomedical (LFCR)

Investment management company Cove Street Capital recently released its “Small Cap Value Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

January 8th, 2024 - Hedge Fund Investor Letters News

Here’s Why Lifecore Biomedical (LFCR) Declined in Q3

Laughing Water Capital, an investment management company, released its third-quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

October 24th, 2023 - Hedge Fund Investor Letters News

Here’s Why Cove Street Capital Sold Lifecore Biomedical (LFCR)

Investment management company Cove Street Capital recently released its “Small Cap Value Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

October 10th, 2023 - Hedge Fund Investor Letters News

Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q4 2023 Earnings Call Transcript

Operator: Good morning, and thank you for joining Lifecore's Fiscal 2023 Fourth Quarter Earnings Call. [Operator Instructions].

Keep Reading →

September 1st, 2023 - News Transcripts

Do You Think Lifecore Biomedical (LFCR) Will Get Sold for a Healthy Premium?

Greenhaven Road Capital, an investment management company, released its second quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

August 12th, 2023 - Hedge Fund Investor Letters News

Lifecore Biomedical (LFCR) Does Not Face Bankruptcy Risk Now

Laughing Water Capital, an investment management company, released its second-quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

July 31st, 2023 - Hedge Fund Investor Letters News

Should You Invest in Lifecore Biomedical (LFCR)?

Investment management company Cove Street Capital recently released its “Small Cap Value Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

July 12th, 2023 - Hedge Fund Investor Letters News

What Makes Lifecore Biomedical (LFCR) an Attractive Investment Opportunity?

Laughing Water Capital, an investment management company, released its first-quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

June 8th, 2023 - Hedge Fund Investor Letters News

Here’s Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR)

Greenhaven Road Capital, an investment management company, released its first quarter 2023 investor letter. A copy of the same can be downloaded here. The fund returned 17% in the first quarter.

Keep Reading →

May 22nd, 2023 - Hedge Fund Investor Letters News

Should You Hold Lifecore Biomedical (LFCR)?

Investment management company Cove Street Capital recently released its “Small Cap Value Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

April 11th, 2023 - Hedge Fund Investor Letters News